Pipeline | Research
| News/Information | About DiaKine | Investor Relations
Home | Contact Us
Inc. is a seed-stage company developing therapies addressing type 1 and
type 2 diabetes and related complications, with market opportunities
exceeding $13 billion.
DiaKine Therapeutics • 338 Raleigh Ave. • Norfolk VA 23507 •firstname.lastname@example.org
©2012 DiaKine Therapeutics. All rights reserved.
Web site designed, developed and hosted by
Atlanta Web Service LLC.
For technical questions or comments about this site, contact the